NCT06712082View on ClinicalTrials.gov

A Study to Learn More About the Study Medicine PF-07264660 in Healthy Chinese Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 24, 2025

Primary Completion Date

September 4, 2025

Study Completion Date

September 4, 2025

Conditions
Healthy
Interventions
DRUG

PF-07264660

PF-07264660 solution for injection (single use only)

OTHER

Placebo

Placebo solution for injection (single use only)

Trial Locations (2)

200040

Huashan Hospital,Fudan University, Shanghai

201107

Huashan Hospital,Fudan University, Shanghai

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06712082 - A Study to Learn More About the Study Medicine PF-07264660 in Healthy Chinese Adult Participants | Biotech Hunter | Biotech Hunter